ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
96,037.83
1.63%
S&P 500
5,837.07
0.01%
Dow Jones
42,364.24
0.16%
US Dollar vs Yen
157.92
0.35%
Brent Oil
79.675
-0.75%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Cartesian Therapeutics Inc (RNAC)

  7. Cartesian Therapeutics Inc (RNAC) ニュース

RNAC

Cartesian Therapeutics (RNAC)

Cartesian Therapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:RNAC
日付受信時刻ニュースソース見出しコード企業名
2025/01/1414 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RNACCartesian Therapeutics Inc
2025/01/1414 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RNACCartesian Therapeutics Inc
2025/01/1406 : 09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNACCartesian Therapeutics Inc
2025/01/1321 : 00GlobeNewswire Inc.Cartesian Therapeutics Highlights Progress and 2025 Strategic Priorities Across Pipeline of mRNA Cell Therapies for Autoimmune DiseasesNASDAQ:RNACCartesian Therapeutics Inc
2025/01/1020 : 01Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:RNACCartesian Therapeutics Inc
2025/01/1020 : 00Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:RNACCartesian Therapeutics Inc
2025/01/1014 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RNACCartesian Therapeutics Inc
2025/01/1014 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RNACCartesian Therapeutics Inc
2025/01/1014 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RNACCartesian Therapeutics Inc
2025/01/0906 : 38Edgar (US Regulatory)Form 424B7 - Prospectus [Rule 424(b)(7)]NASDAQ:RNACCartesian Therapeutics Inc
2025/01/0906 : 33Edgar (US Regulatory)Form 424B7 - Prospectus [Rule 424(b)(7)]NASDAQ:RNACCartesian Therapeutics Inc
2025/01/0906 : 30Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:RNACCartesian Therapeutics Inc
2025/01/0810 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNACCartesian Therapeutics Inc
2025/01/0810 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNACCartesian Therapeutics Inc
2025/01/0810 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNACCartesian Therapeutics Inc
2025/01/0810 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNACCartesian Therapeutics Inc
2025/01/0810 : 04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNACCartesian Therapeutics Inc
2025/01/0810 : 04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNACCartesian Therapeutics Inc
2025/01/0721 : 05GlobeNewswire Inc.Cartesian Therapeutics Announces New Employment Inducement GrantsNASDAQ:RNACCartesian Therapeutics Inc
2025/01/0706 : 21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNACCartesian Therapeutics Inc
2025/01/0706 : 21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNACCartesian Therapeutics Inc
2025/01/0706 : 21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNACCartesian Therapeutics Inc
2025/01/0706 : 20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNACCartesian Therapeutics Inc
2025/01/0706 : 20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNACCartesian Therapeutics Inc
2025/01/0706 : 20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNACCartesian Therapeutics Inc
2025/01/0706 : 19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNACCartesian Therapeutics Inc
2025/01/0706 : 19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNACCartesian Therapeutics Inc
2025/01/0706 : 19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNACCartesian Therapeutics Inc
2024/12/3106 : 14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNACCartesian Therapeutics Inc
2024/12/3106 : 11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNACCartesian Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:RNAC

最近閲覧した銘柄

COIN
SOLUSD
Solana
NYSE
XOM
Exxon Mobil
NYSE
VZ
Verizon Communications
PM
XAUUSD
Gold vs US Dollar
USOTC
RHHBY
Roche (QX)
COIN
AVAXUSD
Avalanche
NASDAQ
AAPL
Apple
FX
USDGBP
US Dollar vs Sterling
NYSE
MRK
Merck
NYSE
MCD
McDonalds
COIN
DOGEUSD
Dogecoin
NYSE
KO
Coca Cola
NASDAQ
GOOGL
Alphabet
COIN
BTCUSD
Bitcoin
AMEX
XLE
Energy Select Sector SPDR
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2025 ADVFN PLC - 全著作権所有